150 related articles for article (PubMed ID: 11896610)
21. Polymorphisms in feline tumour suppressor gene p53. Mutations in an osteosarcoma and a mammary carcinoma.
Mayr B; Reifinger M; Loupal G
Vet J; 1998 Jan; 155(1):103-6. PubMed ID: 9455165
[No Abstract] [Full Text] [Related]
22. Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples.
Angeloni D; Danilkovitch-Miagkova A; Ivanov SV; Breathnach R; Johnson BE; Leonard EJ; Lerman MI
Genes Chromosomes Cancer; 2000 Oct; 29(2):147-56. PubMed ID: 10959094
[TBL] [Abstract][Full Text] [Related]
23. The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse.
Muraoka RS; Sun WY; Colbert MC; Waltz SE; Witte DP; Degen JL; Friezner Degen SJ
J Clin Invest; 1999 May; 103(9):1277-85. PubMed ID: 10225971
[TBL] [Abstract][Full Text] [Related]
24. Sequence of an exon of tumour suppressor p53 gene--a comparative study in domestic animals: mutation in a feline solid mammary carcinoma.
Mayr B; Schaffner G; Kurzbauer R; Reifinger M; Schellander K
Br Vet J; 1995; 151(3):325-9. PubMed ID: 7640960
[TBL] [Abstract][Full Text] [Related]
25. Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration.
Willett CG; Wang MH; Emanuel RL; Graham SA; Smith DI; Shridhar V; Sugarbaker DJ; Sunday ME
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):489-96. PubMed ID: 9533936
[TBL] [Abstract][Full Text] [Related]
26. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice.
Marshall AM; McClaine RJ; Gurusamy D; Gray JK; Lewnard KE; Khan SA; Waltz SE
Mol Cancer; 2012 Jan; 11():2. PubMed ID: 22226043
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
29. Feline Mammary Cancer.
Hassan BB; Elshafae SM; Supsavhad W; Simmons JK; Dirksen WP; Sokkar SM; Rosol TJ
Vet Pathol; 2017 Jan; 54(1):32-43. PubMed ID: 27281014
[TBL] [Abstract][Full Text] [Related]
30. Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines.
Chen Q; Seol DW; Carr B; Zarnegar R
Hepatology; 1997 Jul; 26(1):59-66. PubMed ID: 9214452
[TBL] [Abstract][Full Text] [Related]
31. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of sLex and sLea as candidate prognostic factors for feline mammary gland tumour.
Yoshida S; Yoshida K; Jaroensong T; Lee SJ; Kamida A; Saeki K; Fujita N; Nishimura R; Sasaki N; Nakagawa T
J Feline Med Surg; 2014 Apr; 16(4):257-64. PubMed ID: 24043722
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of immunoexpression of claudin-1 and claudin-7 in feline mammary carcinomas.
Flores AR; Rêma A; Carvalho F; Lopes G; Faustino A; Dias Pereira P
J Comp Pathol; 2014 Nov; 151(4):339-46. PubMed ID: 25246182
[TBL] [Abstract][Full Text] [Related]
34. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
Peace BE; Hughes MJ; Degen SJ; Waltz SE
Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
[TBL] [Abstract][Full Text] [Related]
35. Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer.
Caliari D; Zappulli V; Rasotto R; Cardazzo B; Frassineti F; Goldschmidt MH; Castagnaro M
BMC Vet Res; 2014 Sep; 10():185. PubMed ID: 25249140
[TBL] [Abstract][Full Text] [Related]
36. Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa.
Okino T; Egami H; Ohmachi H; Takai E; Tamori Y; Nakagawa K; Nakano S; Akagi J; Sakamoto O; Suda T; Ogawa M
Int J Oncol; 1999 Oct; 15(4):709-14. PubMed ID: 10493952
[TBL] [Abstract][Full Text] [Related]
37. Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.
Flores AR; Rêma A; Carvalho F; Faustino A; Dias Pereira P
J Comp Pathol; 2014; 150(2-3):169-74. PubMed ID: 24220012
[TBL] [Abstract][Full Text] [Related]
38. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
[TBL] [Abstract][Full Text] [Related]
39. BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway.
Ledet MM; Anderson R; Harman R; Muth A; Thompson PR; Coonrod SA; Van de Walle GR
BMC Cancer; 2018 Apr; 18(1):412. PubMed ID: 29649984
[TBL] [Abstract][Full Text] [Related]
40. Prognostic histopathological and molecular markers in feline mammary neoplasia.
Hughes K; Dobson JM
Vet J; 2012 Oct; 194(1):19-26. PubMed ID: 22841451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
